Indian Pharmaceuticals & Biotech Undervalued based on future growth

Strides Pharma Science

Market Cap: ₹76.0b

Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, and internationally.

Shilpa Medicare

Market Cap: ₹53.3b

Manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, and contract development and manufacturing organisation in India, the United States, Europe, and internationally.

Orchid Pharma

Market Cap: ₹35.3b

A pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India.

IOL Chemicals and Pharmaceuticals

Market Cap: ₹20.7b

Manufactures and sells pharmaceutical and chemical products in India and internationally.